Donald R. Howard, M.D., Ph.D.

Chairman of the Board and CEO

As Chairman and CEO, Dr. Howard leads CellNetix' best-in-class, highly sub-specialized pathology group and laboratories, and was the driving force behind the formation of CellNetix. He has authored numerous publications related to pathology, healthcare, the immunobiology of malignant diseases, particularly breast cancer and lymphomas, and is a regular speaker at national pathology and laboratory conferences. Dr. Howard is Clinical Associate Professor at the University of Washington, School of Medicine. Dr. Howard attended medical school at the Albany Medical College in New York. He completed residencies in Pathology at the University of California in San Francisco and the University of Vermont, College of Medicine and in Internal Medicine and Pathology at the University of Southern California in Los Angeles. Dr. Howard holds a Ph.D. in Experimental Pathology (Immunology) from the University of British Columbia in Vancouver and completed a Terry Fox Fellowship at the National Cancer Institute of Canada. He has additional expertise in strategic and business management of pathology organizations, Immunopathology, and Renal Pathology.